Beta-hydroxybutyrate
Beta-hydroxybutyrate has been studied in 104 papers since 2014: 5 trials and 3 observational studies in people, 56 in animals, 8 in cells, 31 reviews; 41 in the past year. Its furthest trials in people are at phase 2. The newest paper, Nov 9, 2026: “The Role and Mechanisms of β-Hydroxybutyrate in Musculoskeletal Diseases”.
Research on it is growing 9% faster than aging research as a whole: 14 papers in the latest year counted
6 new papers in 30 daysSee all 145 papers on beta-hydroxybutyrate
At a glance
Beta-hydroxybutyrate extends fly lifespan and reduces senescence in mouse cells, with both results repeated by independent labs. A preprint reports shortened D. magna lifespan at 2.5–10 mM, and human-cell inflammation results point both ways. One group reports human results, including lower LDL cholesterol in a trial; some papers declare company ties.
136 findings in 73 papers from 2014 to 2026, 4 of them since April 2026
The findings reach people, from one lab or study; independent labs found the same change in cells, worms or flies and mice. 37 independent labs in 10 countries; 3 trials, none about aging, 1 with no results posted.
“Within the BHB group, fat mass decreased significantly (-2 kg; p < 0.05 vs. baseline)”
9 of its findings point the other way.
- 37 independent labs in 10 countries
- 9 findings against
- 3 trials, none about aging, 1 with no results posted
- Funders: National Natural Science Foundation of China and others
- 12 of 114 findings with company ties
- Human trial5
- Humans3
- Animals47
- Model organisms9
- Cells8
Studies in people
2 studies gave beta-hydroxybutyrate to people and measured what changed.
| What changed | Design | People | Source |
|---|---|---|---|
up: Increases apolipoprotein C-IIp = 0.023 | Randomized trial150 min | 18 peopleBothPatient cohorts | Frontiers in nutrition, Feb 5, 2026 |
down: Decreases fat mass down: Decreases LDL cholesterol | Randomized trialeight-week | 51 peoplemale, n = 20; female, n = 3134.6 ± 6.7 yearsAdults between the ages of 18 and 46 years | Nutrients, Nov 16, 2025 |
What did studies of beta-hydroxybutyrate find?
100Studies of beta-hydroxybutyrate measured 100 outcomes, among them lifespan, cellular senescence and inflammation.
Lifespan
upin B. manjavacas2no changein D. magna1downin D. magna1upin flies1+2
6 studies
Lifespan
upin B. manjavacas2no changein D. magna1downin D. magna1upin flies1+2
Beta-hydroxybutyrate extends lifespan in yeast cells (dose-dependently).
Cellsdose-dependently
Beta-hydroxybutyrate extends lifespan in B. manjavacas (treatment with beta-hydroxybutyrate).
Model organismstreatment with beta-hydroxybutyrate
Beta-hydroxybutyrate extends lifespan in B. manjavacas.
Model organisms
Beta-hydroxybutyrate showed no clear effect on lifespan in D. magna (intermittent exposure administered for 20-day periods).
Model organismsintermittent exposure administered for 20-day periods
Beta-hydroxybutyrate shortens lifespan in D. magna.
Model organisms2.5 – 10 mM
Beta-hydroxybutyrate extends lifespan in worms (BHB supplied during adulthood).
Model organismsBHB supplied during adulthood
Beta-hydroxybutyrate extends lifespan in flies (unbanged flies) (marked extension, no numbers given).
Model organismsunbanged fliesdietary supplementmales
Cellular senescence
downin mouse cells2downin reviews2downin human cells1downin rat cells1
6 studies
Cellular senescence
downin mouse cells2downin reviews2downin human cells1downin rat cells1
Beta-hydroxybutyrate decreases cellular senescence in rat cells (osteoarthritis chondrocytes).
Cellsosteoarthritis chondrocytes
Beta-hydroxybutyrate decreases cellular senescence in human cells (H2O2-induced senescence in HK-2 cells).
CellsH2O2-induced senescence in HK-2 cells
Beta-hydroxybutyrate decreases cellular senescence in podocytes exposed to a diabetic milieu.
Cellsin podocytes exposed to a diabetic milieupodocyte
Beta-hydroxybutyrate inhibits cellular senescence (Stress-induced premature senescence and replicative senescence).
ReviewStress-induced premature senescence and replicative senescencevasculature
Beta-hydroxybutyrate prevents cellular senescence.
Reviewendothelial cells
Beta-hydroxybutyrate inhibits cellular senescence in mouse cells (stress-induced premature senescence and replicative senescence).
Cellsstress-induced premature senescence and replicative senescencevascular cells
Inflammation
upin human cells2downin human cells2downin mice2downin mouse cells1+1
5 studies
Inflammation
upin human cells2downin human cells2downin mice2downin mouse cells1+1
Beta-hydroxybutyrate inhibits inflammation in HFD-induced MASLD mice.
Animalsin HFD-induced MASLD micehippocampus20-week
Beta-hydroxybutyrate decreases inflammation in mice (exogenous administration).
Animalsexogenous administrationliver
Beta-hydroxybutyrate induces inflammation in human cells.
Cells
Beta-hydroxybutyrate inhibits inflammation in mouse cells (LPS-induced; primary mouse microglia and BMDMs).
CellsLPS-induced; primary mouse microglia and BMDMsmicroglia
Beta-hydroxybutyrate inhibits inflammation in human cells (LPS-induced; primary human microglia).
CellsLPS-induced; primary human microgliamicroglia
Beta-hydroxybutyrate inhibits inflammation.
Review
Beta-hydroxybutyrate increases inflammation in human cells (primary human microglia, astrocytes and neurons).
Cellsprimary human microglia, astrocytes and neurons
Beta-hydroxybutyrate decreases inflammation in human cells (LPS-stimulated primary human microglia).
CellsLPS-stimulated primary human microgliamicroglia
Proteostasis
upin mouse cells1upin reviews1
2 studies
Proteostasis
upin mouse cells1upin reviews1
Beta-hydroxybutyrate improves proteostasis in mouse cells.
Cells
Beta-hydroxybutyrate improves proteostasis.
Review
PI3K–AKT signaling
upin mice1downin rat cells1
2 studies
PI3K–AKT signaling
upin mice1downin rat cells1
Beta-hydroxybutyrate activates PI3K–AKT signaling in HFD-induced MASLD mice.
Animalsin HFD-induced MASLD micehippocampus20-week
Beta-hydroxybutyrate inhibits PI3K–AKT signaling in rat cells (osteoarthritis chondrocytes).
Cellsosteoarthritis chondrocytes
Cognitive function
upin mice2
2 studies
Cognitive function
upin mice2
Beta-hydroxybutyrate improves cognitive function in HFD-induced MASLD mice.
Animalsin HFD-induced MASLD mice20-week
Beta-hydroxybutyrate improves cognitive function in aging mice.
Animalsin aging mice
Fecundity
upin D. magna1no changein Daphnia1
2 studies
Fecundity
upin D. magna1no changein Daphnia1
Beta-hydroxybutyrate showed no clear effect on fecundity in Daphnia (fully fed diet).
Model organismsfully fed diet
Beta-hydroxybutyrate increases fecundity in D. magna.
Model organisms
Oxidative stress and ROS signaling
downin mouse cells1downin reviews1
2 studies
Oxidative stress and ROS signaling
downin mouse cells1downin reviews1
Beta-hydroxybutyrate decreases oxidative stress and ROS signaling.
Review
Beta-hydroxybutyrate decreases oxidative stress and ROS signaling in mouse cells (microglia).
Cellsmicroglia
Autophagy
upin mice1upin reviews1
2 studies
Autophagy
upin mice1upin reviews1
Beta-hydroxybutyrate activates autophagy.
Review
Beta-hydroxybutyrate induces autophagy in mice.
Animalsbrain
Infarct volume
no changein mice1downin mice1
1 study
Infarct volume
no changein mice1downin mice1
Beta-hydroxybutyrate showed no clear effect on infarct volume in mice (Treatment initiated 10 hours after MCAO).
AnimalsTreatment initiated 10 hours after MCAObrain
Beta-hydroxybutyrate decreases infarct volume in mice After MCAO.
AnimalsAfter MCAObrain5 g·kg−1·d−1
Fat mass
downin humans1
1 study
Fat mass
downin humans1
Beta-hydroxybutyrate decreases fat mass in humans.
Human trialeight-weekn = 51
Beta-hydroxybutyrate decreases fat mass in humans (adjunct to a hypocaloric diet) (-2 kg, p < 0.05 vs. baseline).
Human trialadjunct to a hypocaloric diet8 weeksn = 51
Apolipoprotein C-II
upin humans1
1 study
Apolipoprotein C-II
upin humans1
Beta-hydroxybutyrate increases apolipoprotein C-II in humans (p = 0.023).
Human trialbeverage150 minn = 18
LDL cholesterol
downin humans1
1 study
LDL cholesterol
downin humans1
Beta-hydroxybutyrate decreases LDL cholesterol in humans.
Human trialeight-weekn = 51
All 100Fewer
What is beta-hydroxybutyrate linked with?
5Studies link beta-hydroxybutyrate with 5 measures, among them MHC-II gene expression, myocardial infarction and colorectal cancer.
MHC-II gene expression
mixedin human cells1mixedin mice1
1 study
MHC-II gene expression
mixedin human cells1mixedin mice1
Beta-hydroxybutyrate is associated with MHC-II gene expression in Raji cells.
Cellsin Raji cells
Beta-hydroxybutyrate is associated with MHC-II gene expression in mice.
Animalsspleen
Myocardial infarction
upin silico1OR 1.407
1 study
Myocardial infarction
upin silico1OR 1.407
Beta-hydroxybutyrate raises the risk of myocardial infarction in silico (univariable Mendelian randomization (IVW)) (OR = 1.407, 95% CI: 1.1660-1.6980).
In silicounivariable Mendelian randomization (IVW)
Colorectal cancer
upin reviews1
1 study
Colorectal cancer
upin reviews1
Beta-hydroxybutyrate raises the risk of colorectal cancer in cancer cells with mutations in APC, KRAS, and TP53.
Reviewin cancer cells with mutations in APC, KRAS, and TP53
Muscle recovery
upin reviews1
1 study
Muscle recovery
upin reviews1
Beta-hydroxybutyrate is associated with muscle recovery in muscle atrophy models.
Reviewin muscle atrophy modelssupplementmuscle
Epigenetic regulation of gene expression
upin reviews1
1 study
Epigenetic regulation of gene expression
upin reviews1
Beta-hydroxybutyrate is associated with epigenetic regulation of gene expression.
Review
Has beta-hydroxybutyrate been tested in people?
0 of 3 about agingYes: 5 trials and 3 observational studies in people have been published, and 3 trials are registered.
Latest change Phase 1 → Phase 2Nov 13, 2026
In trials
Chemotherapy
Phase 2Recruiting1 trial
Phase 2Recruiting1 trial
Phase 1Completed1 trial
Phase 1Completed1 trial
Readouts due
- Dec 31, 2026
- Mar 2027
Trial sponsors
1 trialPhase 144 people
1 trial20 people
Funding
5 grants since 2020National Institute on Aging$9MNational Heart, Lung, and Blood Institute$742KNatural Science Foundation of Guangdong ProvinceCN¥100K
Mechanisms of the signaling metabolite β-hydroxybutyrate in Alzheimer's disease and the aging brain
National Institute on AgingBuck Institute for Research on Aging$806K2020–2031
Natural Science Foundation of Guangdong ProvinceShantou UniversityCN¥100K2026
Buck Institute for Research on AgingStanford University$42.3K2025
National Institute on AgingBuck Institute for Research on Aging$115K2020–2026
National Heart, Lung, and Blood InstituteUniversity of South Carolina at Columbia$244K2022–2024
How this record changed
Summary rewritten as its findings changed.
As it read before
A cell study finds beta-hydroxybutyrate extends yeast lifespan; another reports reduced inflammation in LPS-treated mouse and human cells. A mouse study shows reduced CD8+ T-cell dysfunction and improved CAR T-cell antitumor activity in aged microenvironments; a preprint reports mTOR inhibition in aged mouse splenocytes.
Summary written from the findings.